Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A2583 Lactacystin (Synthetic)1 CitationTarget: ProteasomeSummary: Proteasome inhibitor
-
A2606 Epoxomicin25 CitationSummary: Proteasome inhibitor
-
A4010 Salinosporamide A (NPI-0052, Marizomib)Target: ProteasomeSummary: 20S proteasome inhibitor
-
A1903 E 64d4 CitationSummary: Cysteine protease inhibitor
-
A1933 Carfilzomib (PR-171)10 CitationTarget: ProteasomeSummary: Proteasome inhibitor, epoxomicin analog
-
B1492 PYR-412 CitationTarget: ProteasomeSummary: inhibitor of Ubiquitin-Activating Enzyme (E1)
-
A2571 Pepstatin A1 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: Aspartic protease inhibitor